KATLYN SARGENT SHEETS: Open Payments
NPI 1952903510 · BREMERTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$323 in 10 payments from 7 companies in 2025. Trend: 2023 $335 · 2024 $331 · 2025 $323
Food & beverage: $323
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 4 | $82 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Inspire Medical Systems, Inc. | 1 | $18 |
Products named: AREXVY, BREZTRI, CAPLYTA, Kerendia, JARDIANCE, Leqembi, FASENRA, INSPIRE.
Industry payments across WA — which companies pay providers there.
